Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.155 USD | +11.06% | 0.00% | +28.62% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.62% | 103M | |
+2.10% | 42.75B | |
+47.58% | 41.61B | |
+12.35% | 41.34B | |
-12.36% | 26.59B | |
+8.74% | 25.49B | |
-23.35% | 18.12B | |
+30.90% | 12.24B | |
-1.68% | 11.76B | |
+8.94% | 11B |
- Stock Market
- Equities
- FGEN Stock
- News FibroGen, Inc.
- FibroGen : Commences Phase 3 Trial of Pamrevlumab in Idiopathic Pulmonary Fibrosis